Belpointe Asset Management LLC Makes New Investment in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Belpointe Asset Management LLC acquired a new position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Rating) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 559 shares of the company’s stock, valued at approximately $46,000.

Several other institutional investors and hedge funds have also recently modified their holdings of ACHC. Advisor Group Holdings Inc. raised its stake in shares of Acadia Healthcare by 21.3% in the first quarter. Advisor Group Holdings Inc. now owns 4,111 shares of the company’s stock worth $270,000 after purchasing an additional 721 shares during the last quarter. Bank of Montreal Can raised its stake in shares of Acadia Healthcare by 3.8% in the first quarter. Bank of Montreal Can now owns 7,263 shares of the company’s stock worth $477,000 after purchasing an additional 266 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its stake in shares of Acadia Healthcare by 10.5% in the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 32,961 shares of the company’s stock worth $2,160,000 after purchasing an additional 3,143 shares during the last quarter. Great West Life Assurance Co. Can raised its stake in shares of Acadia Healthcare by 7.4% in the first quarter. Great West Life Assurance Co. Can now owns 48,461 shares of the company’s stock worth $3,262,000 after purchasing an additional 3,349 shares during the last quarter. Finally, Yousif Capital Management LLC raised its stake in shares of Acadia Healthcare by 2.1% in the first quarter. Yousif Capital Management LLC now owns 48,080 shares of the company’s stock worth $3,151,000 after purchasing an additional 982 shares during the last quarter. 99.79% of the stock is owned by hedge funds and other institutional investors.

Acadia Healthcare Stock Performance

NASDAQ:ACHC opened at $70.30 on Thursday. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.42 and a quick ratio of 1.42. The business has a fifty day simple moving average of $71.71 and a two-hundred day simple moving average of $78.09. Acadia Healthcare Company, Inc. has a 1 year low of $63.20 and a 1 year high of $89.85. The company has a market capitalization of $6.47 billion, a P/E ratio of 23.05, a P/E/G ratio of 1.62 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHC – Get Rating) last posted its quarterly earnings results on Monday, February 27th. The company reported $0.70 EPS for the quarter, missing analysts’ consensus estimates of $0.74 by ($0.04). Acadia Healthcare had a return on equity of 10.22% and a net margin of 10.32%. The company had revenue of $675.30 million during the quarter, compared to the consensus estimate of $659.17 million. On average, analysts expect that Acadia Healthcare Company, Inc. will post 3.23 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages have recently commented on ACHC. StockNews.com began coverage on Acadia Healthcare in a research note on Thursday, May 18th. They issued a “hold” rating for the company. Cantor Fitzgerald began coverage on Acadia Healthcare in a research report on Thursday, April 20th. They set a “neutral” rating and a $83.00 price target for the company. Stephens decreased their price target on Acadia Healthcare from $92.00 to $88.00 and set an “equal weight” rating for the company in a research report on Wednesday, March 1st. Mizuho decreased their price target on Acadia Healthcare from $87.00 to $80.00 and set a “neutral” rating for the company in a research report on Monday, March 6th. Finally, Deutsche Bank Aktiengesellschaft downgraded Acadia Healthcare from a “hold” rating to a “sell” rating and decreased their price target for the company from $75.00 to $63.00 in a research report on Thursday, April 20th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, Acadia Healthcare has an average rating of “Hold” and a consensus target price of $89.10.

Acadia Healthcare Company Profile

(Get Rating)

Acadia Healthcare Co, Inc engages in the provision of behavioral healthcare services. It operates through the following business segments: United States (U.S.) Facilities and the United Kingdom (U.K.) Facilities. The U.S. Facilities segment is classified in the following categories: acute inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers, and outpatient community-based services.